South Africa's health minister said the vaccine could be approved and ready for use in Africa by 2028.
Breakdown
- Clinical trials for South Africa's first locally made vaccine in over 50 years have begun.
- The oral cholera vaccine is being developed by Cape Town-based Biovac. 11s
- Authorities consider the trials a milestone for Africa's vaccine production capabilities. 16s
- If successful, Biovac would become the second global producer of the oral cholera vaccine. 42s
- The vaccine could be approved for use in Africa by 2028, depending on trial outcomes. 1m 18s